The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1 –3 According to Individuals’ Gender, Age, and QTc Intervals: A Network Meta-analysis
In conclusion, nadolol was recommended as a relatively effective strategy for LQT2 in order to improve the prognosis of patients during a long follow-up period.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Atenolol | Beta-Blockers | Cardiology | Databases & Libraries | Drugs & Pharmacology | Genetics | Heart | Heart Disease | Inderal | Long QT Syndrome | Nadolol | Study | Toprol